Radiation plus at-home tumor device for locally advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether combining targeted radiation with an at-home “tumor treating fields” device can better control locally advanced pancreatic cancer. It may help by attacking cancer cells in more than one way after prior chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed locally advanced pancreatic adenocarcinoma (a specific type of pancreatic cancer), not pancreatic cysts or other types
- Your cancer has not spread to distant organs (no distant metastasis) and can be treated with radiation in the chest/abdomen area
- You finished at least about 3 months of prior pancreas cancer chemotherapy (like FOLFIRINOX or gemcitabine/nab-paclitaxel) and scans do not show distant progression
- You can do daily life with limited help (ECOG performance status 0–1)
- You meet blood and liver levels needed for treatment (for example, hemoglobin, neutrophils, platelets, bilirubin, and AST/ALT thresholds)
- You can safely use the at-home tumor device (NovoTTF-100L) and have no reasons you can’t get MRI scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of targeted radiation and two oral drugs (defactinib and avutometinib) for people with advanced pancreatic cancer that hasn't spread to distant organs. It may be an option if you've already had at least 2 months of chemo and your cancer is still locally advanced or borderline resectable.
This trial tests a special, high-dose radiation treatment for pancreatic cancer that has not spread but cannot be removed with surgery. The goal is to shrink the tumor and improve control of the cancer in the abdomen.
This trial tests a new, precise form of radiation therapy for locally advanced pancreatic cancer that uses MRI to target the tumor more accurately. It aims to improve treatment effectiveness while reducing damage to surrounding healthy tissue.
This trial tests whether a home-wearable tumor-treating device (Tumor Treating Fields) combined with gemcitabine and albumin-bound paclitaxel works better as first treatment for locally advanced pancreatic cancer. It may help by targeting cancer cells while also using standard chemotherapy.
This trial tests a precise type of radiation therapy guided by MRI for people with locally advanced pancreatic cancer. It aims to treat the tumor while protecting nearby healthy tissue, potentially improving outcomes after chemotherapy.
This trial tests a combination of radiation, an immunotherapy drug (adebrelimab) and a chemotherapy regimen (NALIRIFOX) before any surgery, for people with locally advanced pancreatic cancer. The goal is to shrink the tumor enough to make surgery possible, potentially improving outcomes.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.